Commencement of Trial. The Institution undertakes not to commence recruitment of potential Subjects to participate in the Trial unless and until the Investigator (i) is notified by Biogen or its agents in writing that all approvals, authorisations and documentation necessary to conduct the Trial have been obtained; (ii) has signed the Protocol thereby agreeing to perform all responsibilities detailed therein; and (iii) has signed the investigator statement a template of which is attached to the Investigator agreement. The Institution shall not conduct research covered under this Agreement, nor administer the Product (or, where applicable, a placebo) to a Subject unless and until the Subject has confirmed in writing his receipt and review of and agreement to an informed consent form for the Trial, a sample copy of which shall be provided to the Institution by Biogen.
Commencement of Trial. The Institution shall not commence, and shall not permit the Principal Investigator to commence, recruitment of potential Subjects to participate in the Trial unless and until it is notified by Hexal or its agents in writing that all approvals, authorisations and documentation necessary to conduct the Trial have been obtained. (c)
Commencement of Trial. The Institution and the Investigator undertake not to commence recruitment of potential Subjects to participate
Commencement of Trial. The Institution, the Investigator and the Sub-investigator undertake not to commence recruitment of potential Subjects to participate in the Trial unless and until the Investigator (i) is notified by Biogen Idec or its agents in writing that all approvals, authorisations and documentation necessary to conduct the Trial have been obtained; (ii) has signed the Protocol thereby agreeing to perform all responsibilities detailed therein; and (iii) has signed the investigator statement (attached as Schedule B). The Investigator shall not conduct research covered under this Agreement, nor administer the Product (or, where applicable, a placebo) to a Subject unless and until the Subject has confirmed in writing his receipt and review of and agreement to an informed consent form for the Trial, a sample copy of which shall be provided by the Institution to, and approved by Biogen Idec.
Commencement of Trial. The Institution and the Investigator undertake not to commence recruitment of potential Subjects to participate in the Trial unless and until the Investigator (i) is notified by Biogen or its agents in writing that all approvals, authorisations and documentation necessary to conduct the Trial have been obtained; (ii) has signed the Protocol thereby agreeing to perform all responsibilities detailed therein; and (iii) has signed the investigator statement (attached as Schedule B). The Investigator shall not conduct research covered under this Agreement, nor administer the Product (or, where applicable, a placebo) to a Subject unless and until the Subject has confirmed in writing his receipt and review of and agreement to an informed consent form for the Trial, a signed copy of which shall be provided to the Investigator by Biogen. Biogen schválena společností Biogen. Společnost Biogen poskytne Zkoušejícímu a Zdravotnickému zařízení templát formuláře informovaného souhlasu. will provide the Investigator and the Institution with the template of the Informed Consent Form.
